Dupixent & Libtayo fuel growth despite volatility & Eylea biosimilar risks; margins to recover. Click for an REGN update.

PulteGroup, Inc. is a Buy despite near-term headwinds, supported by a strong backlog and prudent balance sheet management.

The 1980s was a huge decade for television, introducing us to TV hits like Cheers and Magnum, P.I. But while some shows have ...

The real lesson of Abdul El-Sayed’s latest pseudo-scandal.

Morel never reported the alleged assault to police and spent years blaming herself, leading to alcohol misuse. Most sexual ...

Arizona State University is dropping its eminent domain case to seize a 124-year-old historic home in downtown Phoenix.

When he was Tether’s banker, US Commerce Secretary Howard Lutnick ‘managed to kill’ less favorable legislation, a court ...

Wall Street's Buy consensus and a $460 price target sound convincing until you look at what is actually driving Tesla's ...

Peterson to discuss the future of Washington schools under presumptive mayor Janeese Lewis George. This is the Education ...

With her new solo album 'Beard' and a massive return underway for her band The Internet, Syd discusses finding both her voice ...

California has allocated $12.6 million to stabilize its network of 20 Trauma Recovery Centers, though critics assert that the ...

The Bookseller’s investigation into bullying in the book trade has raised concerns about the sector’s approach to staff ...